HemoShear Therapeutics

0 followers


HemoShear Therapeutics develops new treatments for patients with rare metabolic disorders.

Org chart

Brian Wamhoff
Interim CEO

Brian Wamhoff

Collapse
Mark Hayes
Acting Chief Regulatory Officer
Mavis Waller
VP, Clinical Operations
Jeffrey Qureshi
VP, Legal Affairs
Mike Simmers
VP, Operations
Paul Sartori
AVP, Organizational Development & Human Resources
Emile J. Velthuisen
Head of Discovery
Davut U.
Senior Software Engineer
M. Sol Collado
Executive Director, Head Of Discovery Biology
Ryan Feaver
Executive Director, Head Of Exploratory Biology
Christin Hamilton
Research Scientist
Mark Carroll
Scientist I
Napoleon Butler
Sr. Scientist
Jeanne Joslyn
Accounting/hr Coordinator